Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2b randomized double-blind placebo-controlled study of oral MDR-001 in overweight or obesity
CTR20243057Phase 2Completed
- Sponsor
- MindRank
- Start
- Aug 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of MDR-001 in obesity, Overweight, sponsored by MindRank. Started Aug 2024; status: completed.
02
Drugs
MDR-001
03
Conditions
obesityOverweight
Beyond the preview
Go deeper on CTR20243057.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20243057.